SUSAN R SCHECK

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner WARRENVILLE, IL NPI 1831674480

General Payments — all program years on this page

$2,917.87

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 102
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $494.93 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $494.9319

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $243.423
2022 $446.1113
2023 $1,733.4167
2024 $494.9319

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1084907922 Hologic Sales and Service, LLC $15.61 04/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1084907924 Hologic Sales and Service, LLC $18.06 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1084907944 Hologic Sales and Service, LLC $13.70 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087187745 Novartis Pharmaceuticals Corporation $20.50 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087187749 Novartis Pharmaceuticals Corporation $22.51 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087187751 Novartis Pharmaceuticals Corporation $16.65 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108152883 ABBVIE INC. $19.85 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108152885 ABBVIE INC. $26.65 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108152887 ABBVIE INC. $26.59 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110822745 Eisai Inc. $19.40 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117168087 Mirati Therapeutics, Inc. $92.67 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137303276 PharmaEssentia USA Corporation $31.28 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141179824 Incyte Corporation $18.69 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141212839 Incyte Corporation $24.83 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141922790 Merck Sharp & Dohme LLC $20.75 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144983242 Takeda Pharmaceuticals U.S.A., Inc. $19.98 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144983244 Takeda Pharmaceuticals U.S.A., Inc. $22.71 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151315981 JAZZ PHARMACEUTICALS INC. $39.59 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154832320 Pharmacosmos Therapeutics Inc. $24.91 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.